Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1) 24 week results from a multicentre, double-blind, phase 3, randomised contr...

Dandona Paresh, Mathieu Chantal, Phillip Moshe, Hansen Lars, Griffen Steven C, Tschöpe Diethelm, Thorén Fredrik, Xu John, Langkilde Anna Maria, Kollaboráció szervezet: DEPICT-1 Investigators, Piros Györgyike Ágnes, et al
2017